Vir Biotechnology Inc Revenue per Employee (VIR), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Vir Biotechnology Inc   (NASDAQ: VIR)
 

Vir Biotechnology Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Vir Biotechnology Inc 's Revenue per employee fell on a trailing twelve month basis to $ 826,090, but the productivity of Vir Biotechnology Inc 's employees remained above the company average.
Within the Healthcare sector Employees of 413 other companies have achieved higher revenue per employee. While Vir Biotechnology Inc 's total ranking has deteriorated compared to the previous quarter from 2157 to 3122. Vir Biotechnology Inc has 367 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VIR Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change -21.67 % 19582.54 % - 417.78 % -89.92 %
Sales per Employee (TTM) $ 826,090 826,232 178,460 186,801 45,940
VIR's Total Ranking # 3122 # 2157 # 1295 # 1248 #
Seq. Revenue Change -99.92 % - - 26595.83 % -80.23 %

VIR Company Profile >> Back to VIR Efficiency Comparisons >> Compare VIR Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 53
Healthcare Sector # 414
Overall Market # 3122

Revenue per Employee Statistics
High Average Low
$ 6,482,676 $ 1,192,895 $ 3,823
(Sep 30 2022)   (Sep 30 2019)



Financial Statements
Vir Biotechnology Inc 's Revenue MRQ $ 0 Millions Visit VIR's Income Statement
Vir Biotechnology Inc 's Revenues TTM $ 303 Millions Visit VIR's aggregate revenue growth
What are VIR's Sales? Visit VIR's Sales by Segment




Other Ratios
Vir Biotechnology Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
VIR's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for VIR's Competitors
Revenue per Employee for VIR's Suppliers
Revenue per Employee for VIR's Customers

You may also want to know
VIR's Sales Growth Rates VIR's Pe Price to earnings ratio VIR's Receivables Turnover Ratio VIR's Stock Quote
VIR's Net Income Growth Rates VIR's Ps Price to Sales ratio VIR's Sales per Employee VIR's Asset Turnover Ratio
VIR's Net Margin VIR's Pb Price to Book ratio VIR's Financial Strength Ratios VIR's Dividend Payout Ratio
Date modified: 2026-11-05T06:05:17+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Indivior Pharmaceuticals Inc   1,376,000.00 $ 1,376.000  Million 1,000 
Biogen Inc   1,372,973.33 $ 10,297.300  Million 7,500 
Supernus Pharmaceuticals inc   1,326,849.69 $ 865.106  Million 652 
Corcept Therapeutics Inc  1,320,064.38 $ 963.647  Million 730 
Travere Therapeutics Inc   1,309,927.57 $ 651.034  Million 497 
Lantheus Holdings Inc   1,309,212.07 $ 1,561.890  Million 1,193 
Ptc Therapeutics inc   1,166,048.44 $ 1,155.554  Million 991 
Abbvie Inc   1,158,140.35 $ 66,014.000  Million 57,000 
Biomarin Pharmaceutical Inc  1,134,780.19 $ 3,655.127  Million 3,221 
Bridgebio Pharma Inc   1,126,984.51 $ 945.540  Million 839 
Arvinas Inc   1,119,105.69 $ 275.300  Million 246 
Regeneron Pharmaceuticals Inc   1,096,443.87 $ 16,896.200  Million 15,410 
Ani Pharmaceuticals Inc  1,073,549.48 $ 1,041.343  Million 970 
Verastem Inc   983,294.12 $ 100.296  Million 102 
Syndax Pharmaceuticals Inc   971,244.97 $ 289.431  Million 298 
Ardelyx inc   957,505.11 $ 468.220  Million 489 
Axsome Therapeutics Inc   935,424.86 $ 865.268  Million 925 
Alphatec Holdings Inc   919,662.65 $ 839.652  Million 913 
Insmed Inc  888,846.15 $ 1,479.040  Million 1,664 
Carlisle Companies Incorporated  883,644.07 $ 5,213.500  Million 5,900 
Alkermes Plc   855,414.15 $ 1,753.599  Million 2,050 
Pfizer Inc  848,333.33 $ 63,625.000  Million 75,000 
Transmedics Group Inc   810,300.67 $ 727.650  Million 898 
Cerus Corporation  787,493.06 $ 226.798  Million 288 
Ars Pharmaceuticals Inc   749,300.61 $ 122.136  Million 163 
Phathom Pharmaceuticals Inc   740,919.14 $ 274.881  Million 371 
Emergent Biosolutions Inc   721,222.22 $ 649.100  Million 900 
Intuitive Surgical Inc   711,803.07 $ 12,115.600  Million 17,021 
Johnson and Johnson  705,504.26 $ 99,335.000  Million 140,800 
Mannkind Corporation  698,260.14 $ 413.370  Million 592 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.